Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Improving Translational Accuracy02:07

Improving Translational Accuracy

14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K
Improving Translational Accuracy02:07

Improving Translational Accuracy

3.5K
3.5K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

738
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
738

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DiSCO: deconvoluting spatial transcriptomics via combinatorial optimization with a foundational diffusion model.

Briefings in bioinformatics·2026
Same author

BiCLUM: Bilateral contrastive learning for unpaired single-cell multi-omics integration.

PLoS computational biology·2026
Same author

OrgaCCC: Orthogonal graph autoencoders for constructing cell-cell communication networks on spatial transcriptomics data.

PLoS computational biology·2025
Same author

Federated transfer learning with differential privacy for multi-omics survival analysis.

Briefings in bioinformatics·2025
Same author

CoupleVAE: coupled variational autoencoders for predicting perturbational single-cell RNA sequencing data.

Briefings in bioinformatics·2025
Same author

H2GnnDTI: hierarchical heterogeneous graph neural networks for drug-target interaction prediction.

Bioinformatics (Oxford, England)·2025
Same journal

Detection, communication, and individual identification with deep audio embeddings: A case study with North Atlantic right whales.

PLoS computational biology·2026
Same journal

Exploring the structural lexicon of the Proteome via Metric Geometry.

PLoS computational biology·2026
Same journal

Linking retinal sampling in neural encoding models to temporal profiles of visual processing in humans.

PLoS computational biology·2026
Same journal

CAdir: Joint clustering of cells and genes for single-cell transcriptomics with visualization-driven cluster quality assessment.

PLoS computational biology·2026
Same journal

Systematic design of auxotrophic strains and media conditions to probe metabolic functions in E. coli.

PLoS computational biology·2026
Same journal

Neuronal excitability and parameter variability in the Hodgkin-Huxley model.

PLoS computational biology·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K

CoFormerSurv: Collaborative transformer for multi-omics survival analysis.

Gang Wen1,2, Limin Li3

  • 1School of Mathematics and Statistics, Zhengzhou University, Zhengzhou, Henan Province, China.

Plos Computational Biology
|January 7, 2026
PubMed
Summary
This summary is machine-generated.

We introduce CoFormerSurv, a novel Transformer framework for multi-omics survival analysis. This method enhances prognostic predictions by integrating inter-omics and cross-sample information for precision medicine.

More Related Videos

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms
10:41

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

9.6K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K
Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms
10:41

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

9.6K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Area of Science:

  • Biomedicine
  • Computational Biology
  • Genomics

Background:

  • High-throughput sequencing generates vast multi-omics data, crucial for understanding disease complexity.
  • Multi-omics survival analysis improves prognostic predictions for personalized medicine.
  • Transformer architectures show promise but face challenges with right-censored data in multi-omics survival analysis.

Purpose of the Study:

  • To propose an innovative collaborative Transformer framework, CoFormerSurv, for multi-omics survival analysis.
  • To effectively utilize Transformer architecture for extracting complementary information across different omics.
  • To enhance survival prediction performance by addressing challenges in modeling right-censored data.

Main Methods:

  • Developed CoFormerSurv, a collaborative Transformer framework with two architectures: inter-omics Transformer and inter-sample graph Transformer.
  • The inter-omics Transformer uses multi-head self-attention to capture complementary information across omics.
  • The inter-sample graph Transformer integrates structural information from fused multi-omics graphs to explore sample relationships.

Main Results:

  • CoFormerSurv collaboratively generates comprehensive multi-omics features.
  • The framework improves Cox-PH model performance in survival analysis.
  • Experimental results demonstrate superior performance over single-Transformer architectures and existing models.

Conclusions:

  • CoFormerSurv effectively explores complementary information from both inter-omics and cross-sample perspectives.
  • The proposed method advances multi-omics survival analysis for improved prognostic predictions.
  • This framework holds potential for developing more effective personalized treatment strategies in precision medicine.